CellBio Scientific任命查尔斯·米勒为创始首席执行官，领导收购后的增长与创新-动脉网

CellBio Scientific Appoints Charles Miller as Founding CEO to Lead Post-Acquisition Growth and Innovation

CISION 等信源发布 2025-04-10 23:45



可切换为仅中文







PALO ALTO, Calif.

加利福尼亚州帕洛阿尔托

，

April 10, 2025

2025年4月10日

/PRNewswire/ -- CellBio Scientific, a leading global provider of advanced tools and services for biomedical research and preclinical discovery, is excited to announce the appointment of

/PRNewswire/ -- CellBio Scientific，全球领先的生物医学研究和临床前发现先进工具与服务提供商，欣然宣布任命

Charles Miller

查尔斯·米勒

as Chief Executive Officer, effective

作为首席执行官，有效

March 31, 2025

2025年3月31日

. Dr. Miller will lead the company's growth following recent strategic acquisitions and spearhead efforts to scale the business, deepen market impact, and unlock new customer value across life sciences research and drug discovery.

米勒博士将领导公司在近期战略收购后的增长，并引领业务扩展、深化市场影响以及在生命科学研究和药物发现领域释放新的客户价值。

继续阅读

Charles Miller, PhD, MBA

查尔斯·米勒，哲学博士，工商管理硕士

With more than 15 years of leadership experience in drug discovery, diagnostics, and preclinical services, Miller brings a proven track record of transforming organizations and delivering sustainable growth. His previous roles at The Jackson Laboratory and Elephas Biosciences included leading global commercial operations with revenues exceeding .

拥有超过15年在药物发现、诊断和临床前服务领域的领导经验，米勒带来了经验证的组织转型和实现可持续增长的记录。他在杰克逊实验室和Elephas生物科学公司之前的职位包括领导全球商业运营，营收超过。

$500 million

5亿美元

, brand-building in life science and drug discovery and driving market expansion into more than 70 countries.

，生命科学和药物发现领域的品牌建设，以及推动市场扩展到70多个国家。

'I'm honored to join CellBio Scientific at such a pivotal moment in its journey,' said Miller. 'The opportunity to unify exceptional teams, build on a foundation of scientific excellence, and scale solutions that truly advance human health is both exciting and urgent. I look forward to working closely with our customers, partners, and employees to drive innovation, unlock new markets, and shape the future of drug discovery and human health.'.

“我很荣幸能在CellBio Scientific发展历程中的这一关键时期加入，”米勒表示。“有机会整合卓越的团队，在科学卓越的基础上进一步发展，并规模化真正推动人类健康的解决方案，这既令人兴奋又迫切。我期待与我们的客户、合作伙伴和员工紧密合作，推动创新，开拓新市场，并塑造药物研发和人类健康的未来。”

Miller holds a BS and PhD in biomedical sciences from The

米勒持有生物医学科学的学士和博士学位，来自于 The

University of Michigan

密歇根大学

and

和

Michigan State University

密歇根州立大学

, respectively, and an MBA from

，分别，以及一个MBA学位来自

Yale

耶鲁大学

. His management style is characterized by clarity, resilience, and a commitment to building high-performance cultures that deliver measurable impact.

他的管理风格以清晰、坚韧和致力于打造高绩效文化为特点，这种文化能够带来可衡量的影响。

'Charles is exactly the leader we need to drive CellBio Scientific into its next phase of growth,' said

“查尔斯正是我们需要的领导者，可以带领CellBio Scientific进入下一个增长阶段，”

Mark Hilderbrand

马克·希尔德布兰德

, CellBio Board of Directors Chair and Housatonic Partners Managing Director. 'His experience scaling global life sciences platforms, coupled with a deep scientific understanding and a bold vision for innovation, makes him uniquely suited to lead this business forward. Under his leadership, we are confident CellBio will continue to deliver exceptional value to its customers and investors.'.

，CellBio董事会主席和Housatonic Partners董事总经理。“他在扩展全球生命科学平台方面的经验，加上深厚的科学理解以及对创新的大胆愿景，使他成为引领这项业务发展的不二人选。在他的领导下，我们相信CellBio将继续为客户和投资者带来卓越的价值。”

Miller succeeds an interim leadership team that guided the company through a critical phase following formation and recent acquisitions. His appointment signals the company's readiness to accelerate execution on its strategic roadmap, expand into new verticals, and continue building a world-class portfolio of drug discovery tools and services..

米勒接替了一个临时领导团队，该团队在公司成立及近期收购后引导公司度过了一个关键阶段。他的任命表明公司已准备好加速执行其战略路线图，拓展新的垂直领域，并继续构建世界一流的药物发现工具和服务组合。

About CellBio Scientific

关于CellBio科学

CellBio Scientific is a premier provider of life science tools, research services, and clinical solutions advancing the frontiers of biomedical discovery. Formed through the strategic integration of System Biosciences (SBI) and Acepix Biosciences, the company offers a comprehensive portfolio spanning biospecimens, spatial biology, extracellular vesicle technologies, gene delivery systems, cell-based models, and preclinical and clinical histopathology services.

CellBio Scientific 是一家领先的生命科学工具、研究服务和临床解决方案供应商，致力于推进生物医学发现的前沿。该公司由System Biosciences (SBI) 和 Acepix Biosciences 战略整合而成，提供涵盖生物样本、空间生物学、细胞外囊泡技术、基因递送系统、基于细胞的模型以及临床前和临床组织病理学服务的全面产品组合。

With a deep commitment to scientific excellence and innovation, CellBio Scientific empowers researchers, biopharma partners, and clinicians to drive breakthroughs in human health..

怀着对科学卓越和创新的深刻承诺，CellBio Scientific 赋予研究人员、生物制药合作伙伴和临床医生推动人类健康突破的能力。

For more information, contact

更多信息，请联系

Matthew Lorence

马修·洛伦斯

在

mclorence@cellbioscientific.com

。

Contact Information:

联系信息：

CellBio Scientific

细胞生物科学